Chetan Seshadri completed his undergraduate studies at Rutgers University College of Engineering in New Jersey where he majored in Applied Sciences in Engineering with a concentration in Biomedical Engineering. Here, Chetan developed advanced programming skills that would become critical later in…
more
Chetan Seshadri completed his undergraduate studies at Rutgers University College of Engineering in New Jersey where he majored in Applied Sciences in Engineering with a concentration in Biomedical Engineering. Here, Chetan developed advanced programming skills that would become critical later in his career. He then attended Rutgers New Jersey Medical School but took a one-year leave of absence when he was accepted to the HHMI-NIH Research Scholars Program. At the age of 23, Chetan had his first bona fide research experience and learned the fundamentals of immunology working with Dr. Ron Germain at the NIH. He completed medical school and then did his residency in Internal Medicine at Duke University where he gained additional clinical research experience and published his first scientific paper. After completing residency, Chetan served as a field doctor for Médicins sans Frontières (Doctors Without Borders) and experienced first-hand the frustrations of treating infectious diseases like tuberculosis in resource-limited settings. He matched for Infectious Disease fellowship training at the Massachusetts General Hospital / Brigham & Women’s Hospital Combined Training Program and joined Dr. Branch Moody’s lab as a post-doctoral fellow in 2006. He moved to Seattle in 2009 for family reasons and completed a second post-doctoral fellowship in human genetics with Dr. Tom Hawn before establishing his own lab in 2013. He received a Young Physician Scientist Award from ASCI in 2014 and a Clinical Scientist Development Award from the Doris Duke Charitable Foundation in 2016. Over the last ten years, he had made seminal contributions in TB immunology as described below for which he is recognized nationally and internationally. He is a standing member of NIH Study Section, PI of the NIH-funded Seattle TB Research Advancement Center, and was promoted to Full Professor in 2024.
less